|
pA2 online
© Copyright 2004 The British Pharmacological Society
|
022P
University of Buckingham
3th Focused Meeting April 2004
|
Central
leptin gene therapy reduces food intake, body weight and adiposity
and increases thermogenesis in lactating rats
Lecklin, A.1,3,
Dube, M.G.2, Katz, A.1,
Torto, R.2, Kalra, P.S.2
and Kalra, S.P.1 (introduced by
MacDonald, E.3) Univ. of Florida,
Depts. 1Neuroscience and 2Physiology
& Functional Genomics, Gainesville, FL, USA and 3Univ.
of Kuopio, Dept. Pharmacol. & Toxicol., Kuopio, Finland.
|
Print abstract
Search PubMed for:
Lecklin A
Dube MG
Katz A
Torto R
Kalra PS
Kalra SP
|
A recombinant adeno-associated
virus vector encoding the leptin gene (rAAV-lep) has been generated (Chen
et al., 1996). Central administration of rAAV-lep reduces food intake
and body weights in rats. Because this treatment induces long-term changes
in energy balance and nutritional state, its effects on reproduction and
lactation were studied.
Adult female Sprague-Dawley
rats (224±15g, n=19) were used. Rats were injected i.c.v. rAAV-lep
(2.2x1010 particles/10 µl/rat).
The controls received green fluorescent protein (rAAV-GFP) gene. After
cohabitation with males, 6 (from 10) rAAV-lep treated and 7 (from 9) rAAV-GFP
treated rats became pregnant. They were moved into individual cages and
their food intake and body weights were measured biweekly. After parturition,
pups were kept with dams. Females and their pups were sacrificed 4 weeks
after parturition. Serum leptin concentration was determined using a RIA
kit (Linco Research). A dot-blot hybridization analysis for measuring
uncoupling protein 1 (UCP-1) mRNA expression in brown fat (BAT) was performed
(Dhillon et al., 2001). Statistical analyses were Student's t-test or
Mann-Whitney U-test.
After rAAV-lep treatment, parturition with normal numbers of pups occurred.
Birth weights were smaller in rAAV-lep treated group (table 1). At the
age of 4 weeks, pups in rAAV-lep treated group weighed markedly less than
the controls (table 1). In dams, hypothalamic leptin transgene expression
reduced food intake, body weight and the amount of visceral white adipose
tissue (WAT). In line, a reduction in serum level of leptin was found.
Increased UCP-1 mRNA in BAT, reflecting increased energy expenditure through
non-shivering thermogenesis, persisted in these rats (table 1).
Table 1: Effect of central leptin gene therapy on daily food intake (g),
body weight (g), amount of visceral WAT (g), serum leptin level (ng/ml)
and UCP-1 mRNA expression in BAT (arbitrary units) in lactating dams and
body weights (g) of their pups at birth and the age of 4 weeks.
Female
rats |
rAAV-GFP
|
rAAV-lep
|
Pups
|
rAAV-GFP
|
rAAV-lep
|
Food
intake |
60.4
± 4.5
|
46.4
± 2.0*
|
Litter
size (no)
|
10.7
± 1.6
|
9.9
± 1.3
|
Weight |
272.3
± 6.1
|
247.0
± 7.6*
|
Birth
weights
|
6.3
± 0.1
|
5.8
± 0.2*
|
WAT
|
1.1
± 0.3
|
0.1
± 0.0*
|
Weight
(4-weeks)
|
66.4
± 5.3
|
48.0
± 3.9*
|
Leptin
|
1.2
± 0.2
|
0.5
± 0.1*
|
|
|
|
UCP-1
|
745
± 281
|
3500
± 1162*
|
|
|
|
Mean ± s.e.m.
(dams, n=6-7; pups, n=56-73), * p<0.05.
The present results
show that leptin gene therapy may influence the growth of the F1 generation,
because it weakens maternal energy conservation by suppressing food intake
and body adiposity and by increasing energy expenditure through thermogenesis
in dams.
Chen, G. et al., PNAS (1996) 93, 14795-14799.
Dhillon, H. et al., Mol. Ther. (2001) 4,139-145.
|